Timolol Maleate eye drops recalled for defective dropper cap
FDC Limited is recalling Timolol Maleate ophthalmic solution because the dropper cap spike may become lodged in the bottle nozzle, preventing access to the medication. The recall affects one lot distributed to a single U.S. distributor in New Jersey.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II defective container recall with no reported illnesses or injuries. The packaging defect prevents product access but poses no inherent safety risk to the medication itself.
Plain-English summary
FDC Limited is recalling Timolol Maleate Ophthalmic Solution USP, 0.5%, due to a defective container. The spike of the dropper cap may become lodged in the bottle nozzle, making it impossible to dispense the medication.
The affected product consists of 118,104 bottles with lot number 083J033 and an expiration date of September 2025. The product was distributed to one U.S. distributor located in New Jersey.
Patients and healthcare providers who have this product should stop using it and contact their healthcare provider or pharmacist for replacement medication. No adverse events have been reported to date.
The recalled product
- Product
- TIMOLOL MALEATE (TIMOLOL MALEATE)
- Brand
- TIMOLOL MALEATE
- Manufacturer
- FDC Limited
- Category
- Drug — Ophthalmic
- Hazard
- defective-container
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: 083J033
- Exp. Date 09/2025
UPCs (2)
- 0364980513050
- 0364980514057
Distribution
Distributed in 1 state:
- NJ
Related recalls
Same brand · TIMOLOL MALEATE
- HighFDA Recalls Timolol Maleate Eye Drops for Defective Container Cap
FDA (Drugs) · 2025-08-06
- HighPrescription Eye Medication Recalled Due to Defective Cap Design
FDA (Drugs) · 2025-05-14
- HighOphthalmic Eye Drops Recalled for Defective Container Cap Spike
FDA (Drugs) · 2024-12-18
- HighTimolol Maleate Eye Drops Recalled Due to Defective Container
FDA (Drugs) · 2024-11-13
- ModerateFDA recalls Timolol Maleate eye drops due to defective bottle cap
FDA (Drugs) · 2024-08-28
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27